Raymond James & Associates’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $331K | Buy |
13,004
+2,188
| +20% | +$55.7K | ﹤0.01% | 3327 |
|
|
2024
Q2 | $274K | Buy |
10,816
+1,999
| +23% | +$50.6K | ﹤0.01% | 3394 |
|
|
2024
Q1 | $273K | Sell |
8,817
-256
| -3% | -$7.92K | ﹤0.01% | 3396 |
|
|
2023
Q4 | $366K | Buy |
+9,073
| New | +$366K | ﹤0.01% | 3131 |
|
|
2023
Q3 | – | Sell |
-17,291
| Closed | -$297K | – | 3761 |
|
|
2023
Q2 | $297K | Buy |
+17,291
| New | +$297K | ﹤0.01% | 3236 |
|
|
2021
Q4 | – | Sell |
-16,310
| Closed | -$764K | – | 3973 |
|
|
2021
Q3 | $764K | Sell |
16,310
-761
| -4% | -$35.6K | ﹤0.01% | 2751 |
|
|
2021
Q2 | $1.04M | Sell |
17,071
-19
| -0.1% | -$1.16K | ﹤0.01% | 2561 |
|
|
2021
Q1 | $1.05M | Sell |
17,090
-640
| -4% | -$39.4K | ﹤0.01% | 2472 |
|
|
2020
Q4 | $1.26M | Buy |
+17,730
| New | +$1.26M | ﹤0.01% | 2181 |
|